Stifel Reiterates Hold Rating on ResMed (RMD)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| RESMED, Inc. (NYSE: RMD) | Delayed: 246.20 +0.70 (0.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $245.50 | 52 Week High | $70.90 | |||
| Open | $243.94 | 52 Week Low | $50.77 | |||
| Day High | $248.60 | P/E | 110.40 | |||
| Day Low | $243.94 | EPS | $2.23 | |||
| Volume | 899,293 | |||||
